Abstract LB-B19: Re-sensitizing Pancreatic Cancer, targeted siRNA inhibition of HuR
Sign Up to like & getrecommendations! Published in 2018 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.targ-17-lb-b19
Abstract: We have demonstrated that 3DNA nanocarriers can specifically, effectively, and safely deliver siRNA oligos targeted against a pro-survival hub, HuR (the ELAVL1 gene) in an in vivo, pre-clinical model of pancreatic cancer. Pancreatic cancer remains… read more here.
Keywords: targeted sirna; sensitizing pancreatic; hur; pancreatic cancer ... See more keywords